A thorough research of the Schistosomiasis Treatment Market reveals critical gaps and high-priority areas for both therapeutic development and public health intervention. Current research confirms the effectiveness of praziquantel in reducing morbidity but highlights its limited impact on preventing re-infection and its ineffectiveness against the early, migrating stages of the parasite....